Last reviewed · How we verify
QA108 granules
QA108 granules are a gut microbiome modulator.
QA108 granules are a gut microbiome modulator. Used for Treatment of irritable bowel syndrome (IBS).
At a glance
| Generic name | QA108 granules |
|---|---|
| Sponsor | Smilebiotek Zhuhai Limited |
| Drug class | Gut microbiome modulator |
| Modality | Small molecule |
| Therapeutic area | Gastrointestinal |
| Phase | Phase 3 |
Mechanism of action
QA108 granules work by modulating the gut microbiome to produce beneficial effects on the host. The exact mechanism of action is not fully understood, but it is thought to involve the production of short-chain fatty acids and other metabolites that have anti-inflammatory and immunomodulatory effects.
Approved indications
- Treatment of irritable bowel syndrome (IBS)
Common side effects
- Abdominal pain
- Diarrhea
- Flatulence
Key clinical trials
- QA108 Phase III Study in Subjects With Intermediate AMD (PHASE3)
- QA108 Phase II Study in Subjects With Intermediate Age-Related Macular Degeneration (PHASE2)
Primary sources
Every claim on this page is sourced from regulatory or scientific primary sources. See our editorial policy for full methodology.
| Source | Used for |
|---|---|
| ClinicalTrials.gov | Trial enrolment, design, endpoints, results |